Oral Drug of Mirum Becomes First Therapy to be Approved for Alagille Syndrome Treatment in US
On Wednesday, 29th September 2021, the oral drug developed by Mirum Pharmaceuticals Inc., has been the first approve therapy from the purpose of treating the itching in the patients along with a are disorder related to liver known as Alagille Syndrome (ALGS). Chris Peetz, CEO of Mirum said, the Itching has really been devastating for […]
Continue Reading